A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative

PURPOSE: Limited knowledge is available on the incidence of febrile neutropenia (FN) in intermediate-risk patients and the rationale for use of granulocyte colony-stimulating factor (G-CSF) in these patients. We aimed to estimate the rate at which patients associated with intermediate risk (10–20%)...

Descripción completa

Detalles Bibliográficos
Autores principales: Leon Rapoport, Bernardo, Garcia-Morillo, Marcial, Font, Carme, Samoon, Zarka, Jabbar, Adnan Abdul, Kourie, Hampig Raphael, Kayumba, Aline, Esposito, Francis, Popescu, Razvan Andrei, García-Gómez, Jesus, Heyman, Liezl, Smit, Teresa, Krendyukov, Andriy, Mathieson, Nicola, Cooksley, Tim, Anderson, Ronald, Klastersky, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570161/
https://www.ncbi.nlm.nih.gov/pubmed/37828258
http://dx.doi.org/10.1007/s00520-023-08071-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570161/
https://www.ncbi.nlm.nih.gov/pubmed/37828258
http://dx.doi.org/10.1007/s00520-023-08071-0

Ejemplares similares